The largest database of trusted experimental protocols

6 protocols using cd4 and cd8

1

Intracellular IL-21 in KRN.g7 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells from the joint draining LNs of 6 week old KRN.g7 and IDO2 ko KRN.g7 mice were harvested and cultured for 4 hours with 50 ng/ml PMA, 500 ng/ml ionomycin, and 3 μg/ml brefeldin A. After 4 hours, cells were harvested, surface stained for CD4 and CD8 (eBioscience), fixed and permeabilized (IC Fixation and Permeabilization Buffer, eBioscience), then stained for intracellular IL-21 or isotype control. The samples were acquired on a BDFACSCanto II flow cytometer using FACSDiva software and analyzed with FlowJo software.
+ Open protocol
+ Expand
2

Intracellular IL-21 Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells from the joint draining LNs of 6 week old control or IDO2 Ig-treated KRN.g7 mice were harvested and cultured for 4 hours with 50 ng/ml PMA, 500 ng/ml ionomycin, and 3 μg/ml Brefeldin A. After 4 hours, cells were harvested, surface stained for CD4 and CD8 (eBioscience), fixed and permeabilized (IC Fixation and Permeabilization Buffer, eBioscience), then stained for intracellular IL-21 or isotype control. The samples were acquired on a BDFACSCanto II flow cytometer using FACSDiva software and analyzed with FlowJo software.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell suspensions were incubated with 24G2 hybridoma supernatant (to block Fc receptors) and stained using immunofluorescence-labeled antibodies against the following antigens: B220/CD45R, CD3, CD19, CD11b, Ly6G, CD21, CD5, CD44, CD86, CD38, CD138, CD24, CD172a (SIRPα), CD69, CD43, CD40, CD45.2, CD93, IgM, TLR7 and CD62L from BD Biosciences, IA/IE (MHC class II), GL7, CD23, Tbet, CD4 and CD8 from eBioscience and CD11c and SiglecH from Biolegend. For intracellular TLR7 staining, cell suspensions were stained for the indicated extracellular antigens, before fixation with Cytofix (BD Biosciences). Cells were then permeabilized with saponin 0.1% and stained for TLR7. Intracellular T-bet staining was performed using the FoxP3 Fixation/Permeabilization buffer (eBioscience).
Flow cytometry was conducted using an LSR2 (BD Biosciences) and data were analyzed with FlowJo (Tree Star). The full gating strategy that used for flow cytometry analysis is presented in Supporting Information Fig. 6. For splenocyte proliferation experiments, erythrocyte-depleted splenocytes were labeled with CellTrace Violet (Life technologies) according to manufacturer's recommendations.
After 4 days of stimulation, cells were harvested and stained with antibodies for analysis by flow cytometry.
+ Open protocol
+ Expand
4

Flow Cytometric Characterization of Antigen-Specific T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Staining of the cell surface was performed on blood samples and splenocytes after red blood cell lysis. Cells were stained in staining buffer for 30 minutes with allophycocyanin (APC)labeled H-2 K b -SIINFEKL tetramers or APC-labeled H-2D b -RAHYNIVTF (E7 49-57 ) and fluorescently labeled antibodies specific for mouse CD3 (BD Biosciences), CD4, and CD8 (eBiosciences). 7-Aminoactinomycin D (7AAD; Life Technologies) was used for the exclusion of dead cells.
Overnight intracellular cytokine analysis of PBMCs was performed after incubating the cells with 2 mmol/L of OVA8 and 2 mmol/L of OVA17 or 2 mmol/L of E7 SLP in presence of brefeldin A (7.5 mg/mL; BD Biosciences). The next day the assay was developed as described (19, 20) .
+ Open protocol
+ Expand
5

Immunophenotyping of High-Grade Gliomas

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed paraffinembedded (FFPE) sections of primary high-grade gliomas were obtained from 16 patients. HLA class I and programmed deathligand 1 (PD-L1) protein expression and tumor antigen expression were investigated using IHC as described previously (20) (link). Monoclonal antibodies (mAbs) against human HLA class I (OriGene Technologies Inc., Rockville, MD, USA), PD-L1 (Abcam, Cambridge, UK), MAGE-A1 (Thermo Scientific, Flemont, CA, USA), MAGE-A3 (Abnova, Taipei, Taiwan, ROC), WT-1 (DakoCytomation, Glostrup, Denmark), HER1 (DakoCytomation) and gp100 (DakoCytomation) were used as the primary antibodies. The staining was evaluated according to the percentage of tumor cells showing positive membranous staining as follows: score 0, less than 1%; score 1, 1 to 5%; score 2, 5 to 50%; and score 3, more than 50%. Regarding tumor-infiltrating lymphocyte (TIL) staining, monoclonal antibodies against CD4 and CD8 (Thermo Fisher Scientific, Waltham, MA, USA), FoxP3 (Abcam, Cambridge, UK, and CD204 (TransGenic Inc., Kobe, Japan) were used.
+ Open protocol
+ Expand
6

Tumor-Infiltrating Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the tumor-infiltrating immune cells, antibodies against CD4 and CD8 (Thermo Fisher Scientific, Waltham, MA, USA), CD204 (Transgenic Inc., Kobe, Japan), IL-6 (Abcam, Cambridge, UK), TGF-beta1 (R and D Systems, Inc., Minneapolis, MN, USA), cytokeratin (AE1 and AE3, Nichirei Bio., Tokyo, Japan), FoxP3 (Abcam), Granzyme B (Dako, Glostrup, Denmark) and PD-L1 (Abcam) were purchased and used for the IHC and immuno-fluorescence analyses. For reference, the staining level of tumor-infiltrating immune cells was assessed by a semiquantitative estimation of the density of CD8+ T cells inside the tumor site as follows: score 0, no or sporadic CD8+ T cells; score 1, moderate number of CD8+ T cells; score 2, abundant CD8+ T cells; and score 3, highly abundant CD8+ T cells [20 (link)].
For immuno-fluorescence staining, the TGF-beta1, IL-6 and CD204 stains were conducted using an Opal 4-color IHC kit (PerkinElmer Inc., Waltham, MA, USA) and evaluated on a fluorescent Zeiss imager Z1 microscope (Carl Zeiss, Oberkochen, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!